Colleen Marano, PhD, Christian Antoni, MD, Friedrich-Alexander University, Erlangen, Germany; Anna Beutler, MD, Centocor, Inc., Malvern, PA, United States; Gerald Krueger, MD, University of Utah Health Sciences Center, Salt Lake City, UT, United StatesLe texte complet de cet article est disponible en PDF.
Dr. Marano is an employee of Centocor, Inc. Dr. Antoni is an investigator and consultant for infliximab at Centocor. Dr. Krueger is a consultant to Biogen, Genentech, and Centecor; on the sponsored speakers list for Amgen, Biogen, Genentech, and Centecor; has participated in clinical trials for each of these companies. Neither Dr. Krueger nor his family own stock in these companies.
Studies have been funded by research grant from Centocor (IMPACT) or have been done by Centocor (IMPACT 2).